Medicaid expansion under ACA appears to improve cancer clinical trial access

CHICAGO — The Affordable Care Act’s expansion of Medicaid resulted in a nearly threefold increase in the percentage of patients using Medicaid in cancer trials by early 2020, according to study results presented during ASCO Annual Meeting.
The newly enacted Cancer Treatment Act, which mandates that state and Medicaid programs cover routine care costs of clinical trial participation, could further improve access to clinical trials for individuals with Medicaid, researchers noted.
“Our study was motivated by the recognition that the Affordable Care Act Medicaid expansion has

CHICAGO — The Affordable Care Act’s expansion of Medicaid resulted in a nearly threefold increase in the percentage of patients using Medicaid in cancer trials by early 2020, according to study results presented during ASCO Annual Meeting.
The newly enacted Cancer Treatment Act, which mandates that state and Medicaid programs cover routine care costs of clinical trial participation, could further improve access to clinical trials for individuals with Medicaid, researchers noted.
“Our study was motivated by the recognition that the Affordable Care Act Medicaid expansion has